Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More
 
 
Request Information

Bacterial Retention Testing


“Worst Case” Experiments Challenge Each Membrane

Required by all regulatory bodies worldwide, bacterial retention testing (BRT) is a critical step in filter validation. To ensure a “best case” outcome, we conduct BRT using each client’s “worst case” processing conditions and drug product.

Highly skilled Validation Specialists perform microbial retention tests in a controlled laboratory using calibrated equipment and methods that are governed by a robust quality system:
  • Each lab strictly adheres to Parenteral Drug Product (PDA) guidelines and American Society for Testing and Materials (ASTM) standards
  • BRT is conducted using the candidate pharmaceutical under simulated processing conditions to validate sterilizing-grade filter performance.
  • To correctly challenge each membrane, one lot of finished drug product or process fluid is evaluated using three lots of Merck sterilizing-grade, 47 mm membrane discs
    • Including the low bubble point challenges the least retentive membrane
    • Size controls prove that the test organism is the appropriate size
    • Viability tests are performed prior to testing to assure no interference from the drug product
    • Simulated process conditions in drug product provide empirical evidence

View Our Webinars